InflaRx N.V. (IFRX) Financials
IFRX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 137.1 million | 12.2 million |
| 2023-06-30 | 144.6 million | 9.0 million |
| 2023-03-31 | 94.1 million | 8.4 million |
| 2022-12-31 | 109.9 million | 15.1 million |
IFRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -5.6 million | 764440 |
| 2023-06-30 | -12.2 million | 1.1 million |
| 2023-03-31 | -11.5 million | 1.3 million |
| 2022-12-31 | -5.8 million | 497238 |
IFRX Net Income
No data available :(
IFRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 121.4 million | - | 1.2 million |
| 2023-06-30 | 111.2 million | - | 1.3 million |
| 2023-03-31 | 74.5 million | - | 1.4 million |
| 2022-12-31 | 87.8 million | - | 1.5 million |
IFRX Shares Outstanding
IFRX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 22516 | 7.7 million | 3.1 million | 1.7 million |
| 2023-06-30 | 20253 | 11.9 million | 3.9 million | 300159 |
| 2023-03-31 | 6590 | 16.1 million | 3.9 million | - |
| 2022-12-31 | 155055 | 8.9 million | 3.3 million | - |
IFRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 64368 | 270077 |
| 2023-06-30 | - | - |
| 2023-03-31 | - | - |
| 2022-12-31 | - | 151659 |
IFRX
Price: $1.38
52 week price:
Earnings Per Share: -0.84 USD
P/E Ratio: -2.19
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 38219
Market Capitalization: 88.3 million